Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies (2023)
- Authors:
- USP affiliated authors: ROCHA, JULIANA MENDES - EERP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; REIS, JOSÉ AUGUSTO SILVA - FMRP
- Unidades: EERP; FMRP
- DOI: 10.1007/s00406-023-01590-1
- Subjects: ALUCINOGÊNICOS; USO DE MEDICAMENTOS; ALCALOIDES
- Keywords: Ibogaine; Noribogaine; Setting; Safety
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Archives of Psychiatry and Clinical Neuroscience
- ISSN: 0940-1334
- Volume/Número/Paginação/Ano: v. 273, n. 7, p. 1527-1542, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ROCHA, Juliana Mendes et al. Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies. European Archives of Psychiatry and Clinical Neuroscience, v. 273, n. 7, p. 1527-1542, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-023-01590-1. Acesso em: 28 dez. 2025. -
APA
Rocha, J. M., Reis, J. A. S., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2023). Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies. European Archives of Psychiatry and Clinical Neuroscience, 273( 7), 1527-1542. doi:10.1007/s00406-023-01590-1 -
NLM
Rocha JM, Reis JAS, Bouso JC, Hallak JEC, Santos RG dos. Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 7): 1527-1542.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1007/s00406-023-01590-1 -
Vancouver
Rocha JM, Reis JAS, Bouso JC, Hallak JEC, Santos RG dos. Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 7): 1527-1542.[citado 2025 dez. 28 ] Available from: https://doi.org/10.1007/s00406-023-01590-1 - The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
- Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: evidence and mechanisms of action
- Psychedelics in psychiatry
- Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
Informações sobre o DOI: 10.1007/s00406-023-01590-1 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003200811.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
